French drugmaker MedinCell announced on April 126 that it has partnered with AbbVie (NYSE:ABBV) to co-develop and commercialize long-acting injectables in a deal valued...
Biotech Amgen Inc. (NASDAQ: AMGN) has been expanding its portfolio through acquisitions in recent years, giving it access to blockbuster drugs but also adding...
Apple’s (AAPL) smartphone shipments fell about 10% in the first quarter of 2024 as competition from Android smartphone makers vying for the top spot...